Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PSE Product Makes “Highly” Tamper-Resistant Claim With 100% Out Of Reach

This article was originally published in The Tan Sheet

Executive Summary

Westport Pharmaceuticals says a claim of being “highly” resistant to PSE-extraction distinguishes Zephrex-D from the competition, but the distinction alone is not adding up to market-share gains in the nonprescription nasal decongestant space.

Advertisement

Related Content

Extended-Release PSE Points Acura At First Tamper-Resistant Formulation NDA
Extended-Release PSE Points Acura At First Tamper-Resistant Formulation NDA
Tamper-Resistant PSE Takes Big Pharma Stage: Bayer Licenses Acura’s Formulation
Tamper-Resistant PSE Takes Big Pharma Stage: Bayer Licenses Acura’s Formulation
Acura Expects Dominoes To Fall In Retailers Prioritizing Tamper-Resistant PSE
Acura Expects Dominoes To Fall In Retailers Prioritizing Tamper-Resistant PSE
Zephrex-D Solo Show In W.Va. Could Move Tamper-Resistant PSE To Starring Role
Zephrex-D Efficacy Claim Passes NAD Review After Nexafed Firm Objects
Nexafed Gains Rite Aid Sales, But Stumbles In Extraction-Proof PSE Tests
Pseudoephedrine Will Be Behind The Counter Across The Country By October

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106981

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel